Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00469183 · ClinicalTrials.gov registry record · Phase 4
Assessment of Atrophogenic Potential of Triple Combination Cream for Treatment of Melasma
A Phase 4 study, sponsored by Galderma R&D.
- Completed
- Registry status
- Phase 4
- Development phase
- 70
- Enrollment target
NCT00469183: Completed Phase 4 study, sponsored by Galderma R&D.
NCT00469183 is a Phase 4 study that has completed, run by Galderma R&D. The registered enrollment target is 70 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (86% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00469183, a Phase 4 study, has completed, sponsored by Galderma R&D.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 70 participants
- Enrollment target
Study Summary
Evaluate atrophogenic potential of long-term use of Tri-Luma Cream on facial Melasma through biopsy examination.
Interventions
- DRUG Fluocinolone acetonide .1%, hydroquinone 4%, tretinoin .05%
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2006-05 |
| Est. Completion | 2007-04 |
| Phase | Phase 4 |
What the finished NCT00469183 record still lists
NCT00469183 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 70 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (86% lower).
The record links to 0 conditions, and to 1 intervention - of which Fluocinolone acetonide .1%, hydroquinone 4%, tretinoin .05% is the first listed.
NCT00469183 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00469183 about?
NCT00469183 is a clinical study titled "Assessment of Atrophogenic Potential of Triple Combination Cream for Treatment of Melasma". Evaluate atrophogenic potential of long-term use of Tri-Luma Cream on facial Melasma through biopsy examination.
What is the current status of trial NCT00469183?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 70 participants. The study started on 2006-05. Estimated completion is 2007-04.
What interventions are being tested in trial NCT00469183?
The interventions under investigation include: Fluocinolone acetonide .1%, hydroquinone 4%, tretinoin .05% (DRUG).
Who is sponsoring clinical trial NCT00469183?
This trial is sponsored by Galderma R&D, which has 158 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00469183's enrollment target sits among peer trials
70 1043rd of 2000 higher than 931 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00969111 · 70 participants · NA
Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy
- NCT01712620 · 70 participants · Phase 2
Spironolactone for Pulmonary Arterial Hypertension
- NCT02143830 · 70 participants · Phase 2
HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy
- NCT02601339 · 70 participants
NIRS Monitoring in Premature Infants
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia